Absci

Scientist in a lab looking into a microscope
Absci partners with semiconductor company AMD for AI drug discovery
By Anthony Vecchione | 01:37 pm | January 21, 2025
AMD is making a $20 million equity investment to bolster Absci's drug discovery efforts and expand AMDs accelerators and ROCm software.
Scientist in a laboratory setting wearing safety goggles and using a beaker
AstraZeneca, Absci sign $247M agreement to uncover AI-driven cancer drug candidates
By Nathan Eddy | 03:57 pm | December 06, 2023
The companies will leverage Absci's AI-enabled Integrated Drug Creation platform and the pharma giant's oncology research and development expertise.